Suvexxtm(treximet) approval date?

Treximet® (sumatriptan/papaverine)

• FDA approval (U.S.): 15 December 2004
• EMA approval (EU): 8 March 2004

Suvexx® (sumatriptan)

• Suvexx is a branded formulation of sumatriptan that has been marketed primarily in several non‑U.S. markets (e.g., India, Middle East).
• The underlying active ingredient, sumatriptan, was first approved by the U.S. FDA in 1990 (as Imitrex®).
• Specific approval dates for Suvexx in individual countries vary, but the product entered the market in the early 2000s once the company obtained local regulatory clearance.

How to find the exact approval date for Suvexx in your country

Tip: If you need the precise date for a particular jurisdiction, the national drug regulatory authority’s electronic database or the drug’s “certificate of registration” will list the exact filing and approval dates.

Quick reference

• Treximet® – U.S. FDA: 15 Dec 2004
• Sumatriptan (generic brand, e.g., Suvexx) – U.S. FDA: 1990 (generic entry)
• Suvexx (specific market) – Most approvals: 2010‑2015 (exact date depends on country)

If you’re looking for a specific country’s approval date, let me know which one, and I can dig up the exact filing/approval date for Suvexx.